From the Division of Female Pelvic Medicine and Reconstructive Surgery, The University of Oklahoma Health Sciences Center, Oklahoma City.
Division of Female Pelvic Medicine and Reconstructive Surgery, Mercy Hospital, Edmond.
Female Pelvic Med Reconstr Surg. 2020 Apr;26(4):233-238. doi: 10.1097/SPV.0000000000000740.
The objective of this study was to identify differences in pain perception and satisfaction with pain control in women receiving nonsteroidal anti-inflammatory drugs postoperatively.
This was a prospective, randomized controlled trial including urogynecology surgical patients. After surgery, all patients were randomized to receive either intravenous (IV) ketorolac or ibuprofen. The patients completed 3 visual analog scales (VAS) assessing pain at rest, pain with ambulation, and satisfaction with pain control. Postoperative opioid use was also measured.
A total of 224 patients (112 in each arm) were included. Pain scores (SD) at rest in all patients who received ketorolac versus those who received ibuprofen was 2.30 (2.1) versus 2.68 (2.34) (P = 0.20). Pain scores (SD) with ambulation was 3.94 (2.57) versus 4.16 (2.73) (P = 0.57) in patients who received ketorolac and ibuprofen, respectively. Patients who received ketorolac rated their satisfaction with their pain regimen similarly to those who received ibuprofen (P = 0.50). The average amount (SD) of hydromorphone used in the ketorolac and ibuprofen arm was 3.68 (4.58) mg and 4.04 (4.97) mg, respectively (P = 0.58). A subgroup analysis based on type of surgery showed decreased pain at rest (VAS, 2.77 vs 4.88; P = 0.04) and increased satisfaction (VAS, 1.69 vs 4.67; P = 0.003) in patients who had laparotomy and received ketorolac.
There was no difference in pain and satisfaction with IV ketorolac compared with IV ibuprofen in patients who underwent all modalities of urogynecologic surgery. A subgroup of patients who underwent laparotomy had less pain with ketorolac.
本研究旨在比较接受非甾体类抗炎药(NSAIDs)的女性术后疼痛感知和疼痛控制满意度的差异。
这是一项前瞻性、随机对照试验,纳入了妇科泌尿科手术患者。手术后,所有患者均随机接受静脉注射(IV)酮咯酸或布洛芬。患者完成了 3 个视觉模拟量表(VAS)评估静息时疼痛、活动时疼痛和对疼痛控制的满意度。还测量了术后阿片类药物的使用情况。
共纳入 224 名患者(每组 112 名)。接受酮咯酸治疗的所有患者的静息时疼痛评分(标准差)为 2.30(2.1),而接受布洛芬治疗的患者为 2.68(2.34)(P=0.20)。接受酮咯酸和布洛芬治疗的患者活动时的疼痛评分(标准差)分别为 3.94(2.57)和 4.16(2.73)(P=0.57)。接受酮咯酸治疗的患者对其疼痛治疗方案的满意度与接受布洛芬治疗的患者相似(P=0.50)。酮咯酸组和布洛芬组平均使用氢吗啡酮的量(标准差)分别为 3.68(4.58)mg 和 4.04(4.97)mg(P=0.58)。基于手术类型的亚组分析显示,接受剖腹术的患者静息时疼痛减轻(VAS,2.77 比 4.88;P=0.04),满意度增加(VAS,1.69 比 4.67;P=0.003)。
在接受各种妇科泌尿科手术的患者中,静脉注射酮咯酸与静脉注射布洛芬相比,疼痛和对疼痛控制的满意度没有差异。接受剖腹术的亚组患者使用酮咯酸的疼痛减轻。